
Advancing Equitable Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM) Management Strategies: AMCP Great Plains Managed Care Focus
Overview
Friday, September 12, 2025 at 11:15-12:15am ET
Pricing: Participants must be registered for the AMCP Great Plains Day of Education. To participate, visit https://www.amcp.org/great-plains.
Course Description
Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM) is a rare and progressive disease characterized by the misfolding of amyloid fibrils that aggregate and deposit locally in one specific area of the body or deposit systemically, affecting many tissues and organs. Although a rare disease, the estimated prevalence in the United States (U.S.) is 120,000 and growing as we better understand its clinical presentation and appropriate diagnostic methods. However, in the U.S. and notably in the Great Plains region, significant diagnostic gaps are evident among Black and Hispanic/Latinx communities with ATTR-CM.
As experts in all aspects of drug therapy, managed care pharmacists play a pivotal role in shaping patient outcomes, access to treatments, and drug utilization by leveraging evidence-based recommendations to design and implement pharmacy and drug-related medical benefits. This is especially necessary for rare diseases, like ATTR-CM, to optimize clinical and quality programs that meet patient care needs while simultaneously managing the economic burden and complexities of the health care system.
This session will dive into the key data at the national level and in the Great Plains region from clinical trials for novel ATTR-CM treatments, the complexities of health disparities that affect this disease and key managed care considerations.
Instructions for Claiming CPE Credit
AMCP Learn - Claim CPE Instructions.pdf
- Go to amcplearn.org/code in your browser.
- You will see a page that says, “Confirmation Form.” Here you will enter your codes only one at a time.
- Enter the first code that was displayed, then click “Submit.”
- Repeat the last step for each code you received. Then hover over the arrow next to “My Account” and click “Current Activities” to complete the evaluation.
- Click on the title of the activity to begin the evaluation. Then click the “Take Course” button.
- Click on the “Evaluation” item and then click “Start Course” to complete the evaluation.
- Then click “Start course” to fill out the evaluation and click “Submit” at the bottom of the page.
- Once the Evaluation has been submitted, you will be able to click on the “Claim Credit” on the left side of the screen and then “Start.”
- You will see two credit options, ACPE and Certificate of Completion. Check the box next to the credit type(s) you wish to claim.
- ACPE Credit: If your AMCP Learn profile does not already include your DOB and ePID, you will be prompted to update your profile.
- Certificate of Completion: This is a certificate that indicates you completed the session should you need it for your records. No CPE is attached to this certificate.
- Navigate back to the “Pending Activities” page and repeat this process for each CPE activity you attended.
- When you have finished claiming credit for all the session time blocks you attended, you can find your credit record and download certificates of completion by navigating to “My Account” and then “My Activities.” All credit will be sent directly to CPE Monitor within 48-72 hours. If you do not see it reported within 72 hours, please contact us at amcplearn@amcp.org.
Target Audience
Pharmacists who practice in managed care settings.
Learning Objectives
At the completion of this activity, participants should be able to:
- Recognize the clinical indicators for early screening and diagnosis of Transthyretin Cardiac Amyloidosis (ATTR-CM), particularly among a diverse population.
- Identify the burden of health disparities in ATTR-CM disease management on health outcomes and access to care in the United States and the Great Plains region.
- Distinguish the clinical efficacy, safety, monitoring, and patient selection criteria for new and emerging disease-modifying treatment options for ATTR-CM.
- Discuss managed care approaches to optimizing diagnosis and the referral process, health outcomes, and equitable access to care for managing ATTR-CM.
Commercial Support
This activity is supported by an independent medical education grant from BridgeBio.
Faculty
Faculty:
Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP
Adjunct Professor
University of Kentucky, College of Pharmacy
Vice President of Operations
Baptist Health Paducah
Stormi Gale, PharmD, BCCP, BCPS, FHFSA
Cardiology Pharmacy Specialist
Atrium Health Carolinas Medical Center
Accreditation
Accreditation:
The Academy of Managed Care Pharmacy (AMCP) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
ACPE UAN: 0233-0000-25-037-L01-P • Activity Type: Knowledge-Based
Contact Hours: 1.00
Release Date: September 12, 2025 • Expiration Date: October 6, 2025
Activity Fee: Participants must be registered for the AMCP Great Plains Day of Education. Register
Participants should claim continuing pharmacy education (CPE) credit for this home study activity only if they have not claimed credit for the live activity presented at AMCP 2025. CPE credit will be processed through the AMCP Learn portal and reported directly to CPE Monitor. Please allow 72 hours for processing and posting in your NABP account.
Successful Completion to Obtain Credit:
Pharmacists must attend a session in its entirety, participate in session-specific learning assessments, obtain a session-specific attendance code, complete a session evaluation, and record their participation online at amcplearn.org/code no later than 11:59pm PT on Monday, October 6, 2025. No exceptions can be made after this date.
Available Credit
- 1.00 ACPEThe Academy of Managed Care Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
- 1.00 Certificate of Completion